Literature DB >> 7511393

Standardized precision radiotherapy in choroidal metastases.

U Nylén1, E Kock, I Lax, G Lundell, E af Trampe, N Wilking.   

Abstract

Metastases in the choroid of the eye are frequent in patients with disseminated malignancy. We here report the results using the precision radiotherapy technique described by Schipper et al. to treat 14 of 17 consecutive patients (21 eyes) with symptoms from such metastases. A beam defining collimator was used and a lateral field was given with the treated eye individually fixed. Varying fractionations and doses were used. The biologically effective dose for early effects (BED3) was 47 to 90 Gy and for late effects (BED10) 28 to 59 Gy. In 14 eyes (82%) the metastases regressed completely. The visual acuity was stabilized or improved in all patients and none needed local surgery. Three patients developed signs of radiation retinopathy, but only in one case the visual function was compromised. With this standardized technique no individualized dose planning was needed, the risk of radiation cataract was minimized and a dry eye avoided.

Entities:  

Mesh:

Year:  1994        PMID: 7511393     DOI: 10.3109/02841869409098378

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  3 in total

Review 1.  Lung cancer and eye metastases.

Authors:  Sofia Lampaki; Ioannis Kioumis; Georgia Pitsiou; George Lazaridis; Konstantinos Syrigos; Georgia Trakada; Stylianos Kakolyris; Konstantinos Zarogoulidis; Ioannis Mpoukovinas; Aggeliki Rapti; Paul Zarogoulidis
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2014

2.  Precision radiotherapy for brain tumors: A 10-year bibliometric analysis.

Authors:  Ying Yan; Zhanwen Guo; Haibo Zhang; Ning Wang; Ying Xu
Journal:  Neural Regen Res       Date:  2012-08-05       Impact factor: 5.135

3.  Lung squamous cell carcinoma with solitary ocular metastasis and its successful treatment with thoracic surgery and chemotherapy: an interesting and rare case report.

Authors:  Ye Guo; Xu Wang; Jun Xiao; Yinghui Xu; Yangyang Cai; Chao Sun; Kewei Ma
Journal:  BMC Cancer       Date:  2018-10-20       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.